We see a strong increase in thrombectomy interventions as a first line treatment for patients1 with ischemic stroke. There is also a shift from time-based to image-based patient selection in this area. Our Neurovascular suite has been developed to help to address these trends. It can support high levels of procedural efficiency and redefine outcomes for your stroke patients.